Story perspectives

CBD Shows Promise in Reducing Alzheimer's Brain Inflammation

10/15/2025

Summary

Story summary

A new eNeuro study suggests cannabidiol (CBD) may reduce brain inflammation linked to Alzheimer’s disease.
Researchers at Augusta University found daily CBD inhalation in a mouse model decreased inflammatory markers and improved memory.
The study shifts focus from amyloid plaques and tau tangles to immune dysfunction as a key Alzheimer's factor.
The findings indicate CBD could modulate immune pathways, specifically IDO and cGAS, with limitations due to study's animal-model scope.

1 of 1

Story summary

A new eNeuro study suggests cannabidiol (CBD) may reduce brain inflammation linked to Alzheimer’s disease.
Researchers at Augusta University found daily CBD inhalation in a mouse model decreased inflammatory markers and improved memory.
The study shifts focus from amyloid plaques and tau tangles to immune dysfunction as a key Alzheimer's factor.
The findings indicate CBD could modulate immune pathways, specifically IDO and cGAS, with limitations due to study's animal-model scope.